Inducing synthetic lethality using PARP inhibitors - PubMed (original) (raw)
Review
Inducing synthetic lethality using PARP inhibitors
David S Boss et al. Curr Clin Pharmacol. 2010 Aug.
Abstract
The enzyme poly(ADP)-ribose polymerase-1 (PARP-1) plays an important role in the repair of DNA damage via a mechanism called base excision repair (BER). Initially, inhibition of PARP-1 showed to be a promising anti-tumor strategy in preclinical models using BRCA1 and BRCA2 deficient tumor cell lines. More recently, several small molecules targeting PARP-1 entered the clinic and demonstrated compelling anti-tumor activity in patients with BRCA deficient breast and ovarian cancers, and in patients with triple-negative breast cancer. In this review we aim to summarize the most recent advances in the development of PARP inhibitors, with a focus on the clinical data.
Similar articles
- Advances in PARP inhibitors for the treatment of breast cancer.
Dizdar O, Arslan C, Altundag K. Dizdar O, et al. Expert Opin Pharmacother. 2015;16(18):2751-8. doi: 10.1517/14656566.2015.1100168. Epub 2015 Oct 20. Expert Opin Pharmacother. 2015. PMID: 26485111 Review. - The inhibition and treatment of breast cancer with poly (ADP-ribose) polymerase (PARP-1) inhibitors.
De Soto JA, Wang X, Tominaga Y, Wang RH, Cao L, Qiao W, Li C, Xu X, Skoumbourdis AP, Prindiville SA, Thomas CJ, Deng CX. De Soto JA, et al. Int J Biol Sci. 2006;2(4):179-85. doi: 10.7150/ijbs.2.179. Epub 2006 Jun 10. Int J Biol Sci. 2006. PMID: 16810332 Free PMC article. - Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
Heitz F, Harter P, Ewald-Riegler N, Papsdorf M, Kommoss S, du Bois A. Heitz F, et al. Expert Rev Anticancer Ther. 2010 Jul;10(7):1125-36. doi: 10.1586/era.10.53. Expert Rev Anticancer Ther. 2010. PMID: 20645701 Review. - [PARP inhibitors--theoretical basis and clinical application].
Dębska S, Kubicka J, Czyżykowski R, Habib M, Potemski P. Dębska S, et al. Postepy Hig Med Dosw (Online). 2012 May 30;66:311-21. doi: 10.5604/17322693.999033. Postepy Hig Med Dosw (Online). 2012. PMID: 22706117 Review. Polish. - PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside.
Turk AA, Wisinski KB. Turk AA, et al. Cancer. 2018 Jun 15;124(12):2498-2506. doi: 10.1002/cncr.31307. Epub 2018 Apr 16. Cancer. 2018. PMID: 29660759 Free PMC article. Review.
Cited by
- SLOAD: a comprehensive database of cancer-specific synthetic lethal interactions for precision cancer therapy via multi-omics analysis.
Guo L, Dou Y, Xia D, Yin Z, Xiang Y, Luo L, Zhang Y, Wang J, Liang T. Guo L, et al. Database (Oxford). 2022 Aug 27;2022:baac075. doi: 10.1093/database/baac075. Database (Oxford). 2022. PMID: 36029479 Free PMC article. - Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent.
Nguyen D, Zajac-Kaye M, Rubinstein L, Voeller D, Tomaszewski JE, Kummar S, Chen AP, Pommier Y, Doroshow JH, Yang SX. Nguyen D, et al. Cell Cycle. 2011 Dec 1;10(23):4074-82. doi: 10.4161/cc.10.23.18170. Epub 2011 Dec 1. Cell Cycle. 2011. PMID: 22101337 Free PMC article. - Nucleotide Excision Repair in Caenorhabditis elegans.
Lans H, Vermeulen W. Lans H, et al. Mol Biol Int. 2011;2011:542795. doi: 10.4061/2011/542795. Epub 2011 Aug 17. Mol Biol Int. 2011. PMID: 22091407 Free PMC article. - Emerging therapeutic approaches in the management of metastatic castration-resistant prostate cancer.
Antonarakis ES, Armstrong AJ. Antonarakis ES, et al. Prostate Cancer Prostatic Dis. 2011 Sep;14(3):206-18. doi: 10.1038/pcan.2011.24. Epub 2011 May 17. Prostate Cancer Prostatic Dis. 2011. PMID: 21577233 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous